Dr. Khadijeh Mirzaei

Associate Professor
Tehran University of Medical Sciences, Iran


Highest Degree
Ph.D. in Nutrition from Tehran University of Medical Sciences, Iran

Share this Profile

Area of Interest:

Public Health
Community Nutrition
Epidemiology
Cardiac Care
Diabetes Mellitus

Selected Publications

  1. Rahimlou, M., K. Mirzaei, S.A. Keshavarz and A. Hossein-Nezhad, 2016. Association of circulating adipokines with metabolic dyslipidemia in obese versus non-obese individuals. Diabetes Metab. Syndrome: Clin. Res. Rev., 10: S60-S65.
    CrossRef  |  Direct Link  |  

  2. Saboori, S., M.J. Hosseinzadeh-Attar, M. Hosseini, K. Mirzaei and Z. Ahmadivand, 2015. The comparison of serum vaspin and visfatin concentrations in obese and normal weight women. Diabetes Metab. Syndrome: Clin. Res. Rev., 9: 320-323.
    CrossRef  |  Direct Link  |  

  3. Mirzaei, K., A. Hossein-Nezhad, S.M. Eshaghi, H. Ansar and A. Najmafshar, 2015. The relationship between obesity and bone mineral density: Evidence for a role of peroxisome proliferator-activated receptor gamma. Minerva Endocrinol., 40: 177-185.
    Direct Link  |  

  4. Mirzaei, K., A. Hossein-Nezhad, S.A. Keshavarz, F. Koohdani and M.R. Eshraghian et al., 2015. Association of nesfatin-1 level with body composition, dietary intake and resting metabolic rate in obese and morbid obese subjects. Diabetes Metab. Syndrome: Clin. Res. Rev., 9: 292-298.
    CrossRef  |  Direct Link  |  

  5. Mirzaei, K., A. Hossein-Nezhad, M. Karimi, M.J. Hosseinzadeh-Attar, N. Jafari, A. Najmafshar and B. Larijani, 2015. Effect of green tea extract on bone turnover markers in type 2 diabetic patients; A double-blind, placebo-controlled clinical trial study. DARU J. Pharmaceut. Sci., 1: 38-44.
    Direct Link  |  

  6. Hossein-Nezhad, A., N. Khoshniat, M. Maghbooli, Z. Karimi, F. Mirzaei, A. Hosseini and B. Larijani, 2015. Relationship between serum vitamin D concentration and metabolic syndrome among Iranian adults population. DARU J. Pharmaceut. Sci., 17: 1-5.
    Direct Link  |  

  7. Ansar, H., K. Mirzaei, A. Malek, A. Najmafshar and A. Hossein-Nezhad, 2015. Possible resting metabolic rate modification by the circulating RBP4 in obese subjects. Diabetes Metab. Syndrome: Clin. Res. Rev., 9: 19-23.
    CrossRef  |  Direct Link  |  

  8. Mobarakeh, Z.S., K. Mirzaei, N. Hatmi, M. Ebrahimi, S. Dabiran and G. Sotoudeh, 2014. Dietary habits contributing to breast cancer risk among Iranian women. Asian Pac. J. Cancer Prev., 15: 9543-9547.
    Direct Link  |  

  9. Mirzaei, K., M. Xu, Q. Qi, L. de Jonge, G.A. Bray, F. Sacks and L. Qi, 2014. Variants in glucose-and circadian rhythm-related genes affect the response of energy expenditure to weight-loss diets: The pounds lost trial. Am. J. Clin. Nutr., 99: 392-399.
    CrossRef  |  Direct Link  |  

  10. Mirzaei, K., A. Hossein-Nezhad, S.A. Keshavarz, S.M. Eshaghi and F. Koohdani et al., 2014. Insulin resistance via modification of PGC1α function identifying a possible preventive role of vitamin D analogues in chronic inflammatory state of obesity. A double blind clinical trial study. Minerva Med., 105: 63-78.
    Direct Link  |  

  11. Hossein-Nezhad, A., S.M. Eshaghi, Z. Maghbooli, K. Mirzaei, M. Shirzad, B. Curletto and T.C. Chen, 2014. The role of vitamin D deficiency and vitamin D receptor genotypes on the degree of collateralization in patients with suspected coronary artery disease. BioMed Res. Int. 10.1155/2014/304250.
    CrossRef  |  Direct Link  |  

  12. Mirzaei, K., A. Hossein-Nezhad, S.A. Keshavarz, F. Koohdani and A.A. Saboor-Yaraghi et al., 2013. Crosstalk between circulating peroxisome proliferator-activated receptor gamma, adipokines and metabolic syndrome in obese subjects. Diabetol. Metab. Syndrome, Vol. 5. 10.1186/1758-5996-5-79.
    CrossRef  |  Direct Link  |  

  13. Hossein-Nezhad, A., K. Mirzaei, S.A. Keshavarz, H. Ansar, S. Saboori and A. Tootee, 2013. Evidences of dual role of vitamin D through cellular energy homeostasis and inflammation pathway in risk of cancer in obese subjects. Minerva Med., 104: 295-307.
    Direct Link  |  

  14. Hossein-Nezhad, A., F.N. Varzaneh, K. Mirzaei, S. Emamgholipour and M.A. Sahraian, 2013. A polymorphism in the resistin gene promoter and the risk of multiple sclerosis. Minerva Med., 104: 431-438.
    Direct Link  |  

  15. Emamgholipour, S., S.M. Eshaghi, A. Hossein-Nezhad, K. Mirzaei, Z. Maghbooli and M.A. Sahraian, 2013. Adipocytokine profile, cytokine levels and foxp3 expression in multiple sclerosis: A possible link to susceptibility and clinical course of disease. PLoS One, Vol. 8. 10.1371/journal.pone.0076555.
    CrossRef  |  Direct Link  |  

  16. Ahmadi, S., K. Mirzaei, A. Hossein-Nezhad, S.A. Keshavarz and Z. Ahmadivand, 2013. Resting energy expenditure may predict the relationship between obesity and susceptibility to depression disorders. Minerva Med., 104: 207-213.
    Direct Link  |  

  17. Mirzaei, K., S. Ahmadi, A. Hossein-Nezhad and F. Mokhtari, 2012. Potential role of OPG/RANKL system and FokI genotypes in pathogenesis and clinical manifestations in multiple sclerosis. Minerva Med., 103: 313-321.
    Direct Link  |  

  18. Mirzaei, K., A. Hossein-Nezhad, S. Emamgholipour, H. Ansar, M. Khosrofar, A. Tootee and S. Alatab, 2012. An exonic Peroxisome Proliferator-Activated Receptor-γ Coactivator-1α variation may mediate the resting energy expenditure through a potential regulatory role on important gene expression in this pathway. J. Nutrigenet. Nutrigenom., 5: 59-71.
    CrossRef  |  Direct Link  |  

  19. Hossein-Nezhad, A., K. Mirzaei, H. Ansar, S. Emam-Gholipour, A. Tootee and S.A. Keshavarz, 2012. Obesity, inflammation and resting energy expenditure: Possible mechanism of progranulin in this pathway. Minerva Endocrinol., 37: 255-266.
    Direct Link  |  

  20. Hossein-Nezhad, A., K. Mirzaei, H. Ansar, G. Khooshechin, Z. Ahmadivand and S.A. Keshavarz, 2012. Mutual role of PGRN/TNF-α on osteopenia developing in obesity's inflammation state. Minerva Med., 103: 165-175.
    Direct Link  |  

  21. Ahmadi, S., K. Mirzaei, A. Hossein-Nezhad and G. Shariati, 2012. Vitamin D receptor FokI genotype may modify the susceptibility to schizophrenia and bipolar mood disorder by regulation of dopamine D1 receptor gene expression. Minerva Med., 103: 383-391.
    Direct Link  |  

  22. Mirzaei, K., A. Hossein-Nezhad, S. Aslani, S. Emamgholipour, M. Karimi and S. Keshavarz, 2011. Energy expenditure regulation via macrophage migration inhibitory factor in obesity and in vitro anti-macrophage migration inhibitory factor effect of Alpinia officinarum hance extraction. Endocrine Pract., 18: 39-48.
    CrossRef  |  

  23. Mirzaei, K., A. Hossein-Nezhad, M. Chamari and S. Shahbazi, 2011. Evidence of a role of ANGPTL6 in resting metabolic rate and its potential application in treatment of obesity. Minerva Endocrinol., 36: 13-21.
    Direct Link  |  

  24. Mirzaei, K., A. Hossein-Nezhad, F. Mokhtari, A. Najmafshar and M.K. Nikoo, 2011. VISFATIN/NAMPT/PBCEF and cytokine concentration in multiple sclerosis patients compared to healthy subjects. Eur. J. Inflammat., 9: 31-37.

  25. Hossein-Nezhad, A., S.M. Ahmadi and F. Karimi, 2011. Comparison of incidence of pregnancy induced hypertension in gestational diabetes mellitus and healthy pregnant women. J. Diabetes Metab. Disorders, Vol. 10. .
    Direct Link  |  

  26. Hossein-Nezhad, A., K. Mirzaei, Z. Maghbooli, A. Najmafshar and B. Larijani, 2011. The influence of folic acid supplementation on maternal and fetal bone turnover. J. Bone Mineral Metab., 29: 186-192.
    CrossRef  |  Direct Link  |  

  27. Hossein-Nezhad, A., K. Mirzaei, S. Aslani, A. Tootee and F. Karimi, 2011. MIF expression in induced peripheral blood mononuclear cells by vitamin D3 and its potential correlation with resting metabolic rate in obesity. Eur. J. Inflammation, 9: 125-134.
    CrossRef  |  

  28. Hossein-Nezhad, A., F.N. Varzaneh and K. Mirzaei, 2011. Association of the FokI polymorphism in the vitamin D receptor gene with vertebral fracture in Iranian postmenopausal women. Endocrine Pract., 17: 826-827.

  29. Aslani, S., A. Hossein-Nezhad, Z. Maghbooli, K. Mirzaei and F. Karimi, 2011. Genetic variation in macrophage migration inhibitory factor associated with gestational diabetes mellitus and metabolic syndrome. Hormone Metab. Res., 43: 557-561.

  30. Aslani, S., A. Hossein-Nezhad, K. Mirzaei, Z. Maghbooli, S.N. Asgarabad and F. Karimi, 2011. Tandem repeats of the CATT element of macrophage migration inhibitory factor gene may predict gestational diabetes mellitus severity. Eur. J. Inflammation, 9: 185-191.
    Direct Link  |  

  31. Aslani, S., A. Hossein-Nezhad, K. Mirzaei, Z. Maghbooli, A.N. Afshar and F. Karimi, 2011. VDR FokI polymorphism and its potential role in the pathogenesis of gestational diabetes mellitus and its complications. Gynecol. Endocrinol., 27: 1055-1060.
    CrossRef  |  

  32. Alatab, S., A. Hossein-Nezhad, K. Mirzaei, F. Mokhtari, G. Shariati and A. Najmafshar, 2011. Inflammatory profile, age of onset and the MTHFR polymorphism in patients with multiple sclerosis. J. Molecular Neurosci., 44: 6-11.
    Direct Link  |  

  33. Mirzaei, K., M.J. Hosseinzadeh-Attar, A. Hossein-Nezhad, M. Karimi and M. Kamalinejad et al., 2010. Visfatin genotype may influence the effects of green tea extract (Camellia sinensis) in type 2 diabetes patients. Double blind placebo-controlled clinical trial study. Medica Italiana Archivio Scienze Mediche, 169: 137-148.

  34. Maghbooli, Z., A. Hossein-Nezhad, K. Mirzaei, F. Karimi, A. Besharati, K. Omidfar and B. Larijani, 2010. Association between retinol-binding protein 4 concentrations and gestational diabetes mellitus and risk of developing metabolic syndrome after pregnancy. Reprod. Sci., 17: 196-201.
    Direct Link  |  

  35. Hossein-Nezhad, A., Z. Maghbooli, M.M. Rahmani and B. Larijani, 2010. Resistin, adiponectin and visfatin; can adipocytokines predict gestational diabetes mellitus and early post partum metabolic syndrome? J. Diabetes Metab. Disorders, Vol. 9. .
    Direct Link  |  

  36. Hossein-Nezhad, A., Z. Maghbooli, M.M. Rahmani and B. Larijani, 2010. Osteocalcin and cross laps status among women with gestational diabetes mellitus during pregnancy. J. Diabetes Metab. Disorders, Vol. 9. .
    Direct Link  |  

  37. Hossein-Nezhad, A., M.K. Nikoo, K. Mirzaei, F. Mokhtarei and H.A. Meybodi, 2010. Comparison of the bone turn-over markers in patients with multiple sclerosis and healthy control subjects. Eur. J. Inflammat., 8: 67-73.
    Direct Link  |  

  38. Hossein-Nezhad, A., F. Mirzaei, F. Biramijamal, R. Mirfakhraei and N. Sedighi, 2010. Variation in the COX-2 gene may modify the effect of alendronate on vertebral fracture prevention. Eur. J. Inflammation, 8: 143-149.
    Direct Link  |  

  39. Emamgholipour, S., A. Hossein-Nezhad, M.S.A. Mohajerani and M. Shirzad, 2010. Genetic variants at the resistin gene promoter might have a role in atherogenesis in patients with coronary artery disease. J. Diabetes Metab. Disorders, Vol. 9. .
    Direct Link  |  

  40. Mohammadi, S., M.J. Hosseinzadeh Atar, A. Hossein-Nezhad, S.H. Hosseini and M.R. Eshraghian et al., 2009. The prevalence of cardiovascular risk factors and correlation with nutritional status in patients with type 2 diabetes. ARYA Atheroscler. J., 5: 11-17.
    Direct Link  |  

  41. Mirzaei, K., A. Hossein-Nezhad, M. Hosseinzadeh-Attar, N. Jafari, A. Najmafshar and B. Larijani, 2009. Variation in the visfatin gene may alter the required dosage of Oral antidiabetic agents in type 2 diabetic patients. J. Diabetes Metab. Disord., 8: 87-94.
    Direct Link  |  

  42. Mirzaei, K., A. Hossein-Nezhad, H.A.M. Javad, N. Jafari, A. Najmafshar, N. Mohammadzadeh and B. Larijani, 2009. Visfatin genotype may modify the insulin resistance and lipid profile in type 2 diabetes patients. Minerva Endocrinol., 34: 273-279.
    Direct Link  |  

  43. Hossein-Nezhad, A., Z. Maghbooli and B. Larijani, 2009. Maternal glycemic status in GDM patients after delivery. J. Diabetes Metab. Disorders, 8: 95-104.
    Direct Link  |  

  44. Hossein-Nezhad, A., M. Hosseinzadeh-Attar, A. Najmafshar, N. Jafari, M. Rahmani and B. Larijani, 2009. Relationship between genotype and serum levels of adipokines and bone mineral density in type 2 diabetes mellitus patients. J. Diabetes Metab. Disorders, 8: 77-86.
    Direct Link  |